(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
Similarly, Who owns Bionano Genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Is BNGO in ETF? Bionano Genomics is a life sciences instrumentation company in the genome analysis space.
…
| ETF | BNGO |
|---|---|
| Shares Out. | 289.18M |
| Market Cap. | 615.96M |
| Div/Shr | 0.00 |
| Div Yield | 0.00 |
Thereof, Is BNGO in any ETFs?
ETF.com Insight
Bionano Genomics, Inc. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. BNGO has around 17.2M shares in the U.S. ETF market. The largest ETF holder of BNGO is the iShares Russell 2000 ETF (IWM), with approximately 6.72M shares.
Does Ark hold BNGO?
Does ARK Invest in BNGO: The Bottom Line. At this time, ARK does not invest in BNGO. With that said, the company does appear to have some promise in its own right. Like all speculative small-cap companies, Bionano Genomics is a risky stock to own.
Where is BNGO located?
The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
What institutions are buying BNGO?
Bionano Genomics (NASDAQ:BNGO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 2/14/2022 | Nuveen Asset Management LLC | 0.357% |
| 2/14/2022 | Barclays PLC | 0.123% |
| 2/14/2022 | GSA Capital Partners LLP | 0.019% |
| 2/14/2022 | Mutual Advisors LLC | 0.017% |
What sector is BNGO stock?
Key Data
| Label | Value |
|---|---|
| Sector | Capital Goods |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| 1 Year Target | $11.00 |
| Today’s High/Low | $2.77/$2.57 |
What kind of company is Bionano genomics?
Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.
What does BNGO company do?
Company Description
The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
Who owns the most stock in NIO?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 2.99% | 40,093,147 |
| The Vanguard Group, Inc. | 2.76% | 36,994,474 |
| SSgA Funds Management, Inc. | 2.45% | 32,887,731 |
| Goldman Sachs & Co. LLC (Private … | 1.73% | 23,202,778 |
Did BlackRock buy NIO stock?
2022-02-10 – BlackRock Inc. has filed a 13F-HR form disclosing ownership of 64,036,975 shares of Nio Inc (US:NIO) with total holdings valued at $2,028,693,000 USD as of 2021-12-31.
What percent of NIO is public?
Public Company Ownership
Public companies currently own 8.5% of NIO stock. It’s hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it’s worth watching this space for changes in ownership.
Did BlackRock buy BNGO stock?
ownership in BNGO / BioNano Genomics Inc – 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. ownership in BNGO / BioNano Genomics Inc.
| Security | BNGO / BioNano Genomics Inc |
|---|---|
| Institution | BlackRock Inc. |
| Latest Disclosed Ownership | 18,660,129 shares |
| Ownership | 6.50% |
How many shares are there of BNGO?
BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
Who is BNGO stock?
(BNGO) Stock Price, News, Quote & History – Yahoo Finance.
…
Performance Outlook.
| Previous Close | 2.3200 |
|---|---|
| Bid | 2.1800 x 27000 |
| Ask | 2.2300 x 29200 |
| Day’s Range | 2.1800 – 2.3200 |
| 52 Week Range | 1.6200 – 9.1200 |
How do I buy BNGO stock?
How to Buy BNGO Stock
- Pick a brokerage. Retail investors like yourself are buying stocks through the brokers. …
- Decide how many shares you want. After you open and fund your brokerage account you’re ready to buy the shares. …
- Choose your order type. …
- Execute your trade.
How many shares does BNGO have?
BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
How many employees does BioNano genomics?
How many employees does BioNano Genomics have? BioNano Genomics has 77 employees.
How does BioNano genomics make money?
Revenue is produced by either directly selling the data to outsiders or by leveraging it for internal reasons, such as increasing the efficacy of advertising.
Who are BioNano genomics competitors?
13 Competitors
BioNano Genomics’s competitors are BioDiscovery, Fluxion Biosciences, IRX Therapeutics, Hepregen, Genvault Corporation and more.
Join TheMoney.co community and don’t forget to share this post !